Karolinska University Hospital signs agreement to run SAGA’s ultrasensitive liquid biopsy tests in-house

Karolinska University Hospital signs agreement to run SAGA’s ultrasensitive liquid biopsy tests in-house

LUND, Sweden — /October 8, 2019/ — SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces it has entered a “lab-in-lab” customer agreement with Karolinska University Hospital, Department of Pathology, serving the greater Stockholm healthcare region.  As part of the […]

SAGA lands agreement with Region Örebro University Hospital to deploy ultra sensitive liquid biopsy testing in lung cancer

SAGA lands agreement with Region Örebro University Hospital to deploy ultra sensitive liquid biopsy testing in lung cancer

LUND, Sweden — /September 9, 2019/ — SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, today announces it has entered a “lab-in-lab” customer agreement with the University Hospital Örebro (USÖ), Division of Laboratory Medicine, serving the healthcare region of Örebro County. […]

SAGA appoints new Director of Finance

SAGA appoints new Director of Finance

LUND, Sweden — /February 11, 2019/ — SAGA Diagnostics AB, a genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients using a simple blood sample, today announces the appointment of a new Director of Finance, Henrik Simonsen, a veteran strategic CFO with over 20 years of executive and corporate finance […]